PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WT vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WT and ABBV is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

WT vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree Inc. (WT) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-4.71%
4.09%
WT
ABBV

Key characteristics

Sharpe Ratio

WT:

0.97

ABBV:

0.70

Sortino Ratio

WT:

1.48

ABBV:

1.03

Omega Ratio

WT:

1.19

ABBV:

1.16

Calmar Ratio

WT:

0.45

ABBV:

0.91

Martin Ratio

WT:

2.44

ABBV:

2.11

Ulcer Index

WT:

11.92%

ABBV:

8.21%

Daily Std Dev

WT:

30.14%

ABBV:

24.76%

Max Drawdown

WT:

-99.93%

ABBV:

-45.09%

Current Drawdown

WT:

-55.17%

ABBV:

-0.54%

Fundamentals

Market Cap

WT:

$1.37B

ABBV:

$348.39B

EPS

WT:

$0.33

ABBV:

$2.39

PE Ratio

WT:

28.39

ABBV:

82.57

Total Revenue (TTM)

WT:

$427.74M

ABBV:

$56.33B

Gross Profit (TTM)

WT:

$320.36M

ABBV:

$41.47B

EBITDA (TTM)

WT:

$91.28M

ABBV:

$18.15B

Returns By Period

In the year-to-date period, WT achieves a -11.05% return, which is significantly lower than ABBV's 14.11% return. Over the past 10 years, WT has underperformed ABBV with an annualized return of -4.60%, while ABBV has yielded a comparatively higher 17.57% annualized return.


WT

YTD

-11.05%

1M

-4.50%

6M

-4.71%

1Y

26.87%

5Y*

15.29%

10Y*

-4.60%

ABBV

YTD

14.11%

1M

16.38%

6M

4.09%

1Y

18.88%

5Y*

21.23%

10Y*

17.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WT vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WT
The Risk-Adjusted Performance Rank of WT is 7070
Overall Rank
The Sharpe Ratio Rank of WT is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of WT is 7070
Sortino Ratio Rank
The Omega Ratio Rank of WT is 6868
Omega Ratio Rank
The Calmar Ratio Rank of WT is 6565
Calmar Ratio Rank
The Martin Ratio Rank of WT is 6969
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6868
Overall Rank
The Sharpe Ratio Rank of ABBV is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 6060
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6363
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 7777
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WT vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree Inc. (WT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WT, currently valued at 0.97, compared to the broader market-2.000.002.000.970.70
The chart of Sortino ratio for WT, currently valued at 1.48, compared to the broader market-4.00-2.000.002.004.006.001.481.03
The chart of Omega ratio for WT, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.16
The chart of Calmar ratio for WT, currently valued at 0.45, compared to the broader market0.002.004.006.000.450.91
The chart of Martin ratio for WT, currently valued at 2.44, compared to the broader market-10.000.0010.0020.0030.002.442.11
WT
ABBV

The current WT Sharpe Ratio is 0.97, which is higher than the ABBV Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of WT and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
0.97
0.70
WT
ABBV

Dividends

WT vs. ABBV - Dividend Comparison

WT's dividend yield for the trailing twelve months is around 1.28%, less than ABBV's 3.13% yield.


TTM20242023202220212020201920182017201620152014
WT
WisdomTree Inc.
1.28%1.14%1.73%2.20%1.96%2.24%2.48%1.80%2.55%2.87%3.64%0.51%
ABBV
AbbVie Inc.
3.13%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

WT vs. ABBV - Drawdown Comparison

The maximum WT drawdown since its inception was -99.93%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WT and ABBV. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-55.17%
-0.54%
WT
ABBV

Volatility

WT vs. ABBV - Volatility Comparison

The current volatility for WisdomTree Inc. (WT) is 4.98%, while AbbVie Inc. (ABBV) has a volatility of 7.42%. This indicates that WT experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
4.98%
7.42%
WT
ABBV

Financials

WT vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between WisdomTree Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab